IP Library Granted Patent US 7,445,893
Granted Patent B2
US 7,445,893 · App. 10/719,185 · Granted Nov 4, 2008

Sampling method for amplification reaction analysis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,445,893
App. No.
10/719,185
Granted
Nov 4, 2008
Kind
B2
Abstract

The invention provides sampling methods that permit the quantitative analysis of nucleic acid amplification reactions. The methods disclosed permit quantitative expression analysis of multiple genes or transcription units, both in the same amplification reaction and in multiple amplification reactions. In one aspect, the methods disclosed include, briefly, dispensing or withdrawing an aliquot from a reaction mixture at plural stages of an amplification regimen, separating and detecting nucleic acids in the aliquot, determining the quantity of a plurality of separated nucleic acid species in the aliquot, and for each separated nucleic acid species from each stage, correlating the quantity of the species with the stage at which the aliquot comprising the species was dispensed, thereby generating a profile of the amplification.

Claims (122)

1. A method of analyzing a nucleic acid amplification comprising:

providing a nucleic acid amplification reaction mixture comprising a plurality of different amplification templates;

subjecting said reaction mixture to an amplification regimen;

dispensing or withdrawing an aliquot from said reaction mixture at plural stages during said amplification regimen;

separating and detecting nucleic acids in said aliquot, wherein said separating comprises capillary electrophoresis;

determining the quantity of a plurality of separated nucleic acid species in said aliquot, wherein said plurality of different amplification templates comprises at least five different amplification templates and

for each said separated nucleic acid species from each said stage, correlating the quantity of said species with the stage at which said aliquot comprising said species was dispensed, wherein said correlating generates an amplification profile of said nucleic acid amplification, and wherein said amplification profile provides quantitative information regarding the abundance of said plurality of different amplification templates in said amplification reaction mixture at the start of said amplification regimen.

2. The method of claim 1 wherein said plurality of different amplification templates comprises at least ten different amplification templates.

3. The method of claim 1 wherein said plurality of different amplification templates comprises at least 20 different amplification templates.

4. The method of claim 1 wherein said plurality of different amplification templates comprises at least 50 different amplification templates.

5. The method of claim 1 wherein said plurality of different amplification templates comprises at least 100 different amplification templates.

6. The method of claim 1 wherein said plurality of different amplification templates comprises at least 200 different amplification templates.

7. The method of claim 1 wherein a plurality of amplification reaction mixtures is subjected to said method.

8. The method of claim 7 wherein said plurality of amplification reaction mixtures is subjected to said method simultaneously.

9. The method of claim 1 wherein said method generates an amplification profile for a plurality of amplified nucleic acid species.

10. The method of claim 1 wherein said amplification profile is a transcriptional profile.

11. The method of claim 1 wherein said nucleic acid amplification regimen comprises thermal cycling.

12. The method of claim 1 wherein said nucleic acid amplification regimen comprises isothermal cycling.

13. The method of claim 1 wherein said nucleic acid amplification regimen comprises PCR.

14. The method of claim 1 wherein said nucleic acid amplification regimen comprises a method selected from the group consisting of ligase-mediated amplification, NASBA, and rolling circle amplification.

15. The method of claim 1 wherein said aliquot is dispensed into a receptacle having a plurality of aliquot-receiving sites.

16. The method of claim 15 wherein said receptacle is a multiwell plate.

17. The method of claim 1 wherein said aliquot is dispensed into or onto a receptacle capable of holding a plurality of aliquots without mixing among said aliquots.

18. The method of claim 15 wherein said receptacle comprises a plurality of CE capillaries.

19. The method of claim 1 wherein said amplification regimen is cyclic.

20. The method of claim 19 wherein said dispensing or withdrawing is performed after each of a plurality of cycles.

21. The method of claim 19 wherein said dispensing or withdrawing is performed after every cycle in said regimen.

22. The method of claim 15 wherein said detecting comprises detection of one or more fluorescent labels.

23. The method of claim 15 wherein said detecting comprises mass spectrometry.

24. The method of claim 1 wherein said amplification regimen is performed in a container, and wherein said aliquot dispensing is performed by withdrawing said aliquot from said container.

25. The method of claim 16 wherein said container is a well or a test tube.

26. The method of claim 1 wherein said amplification regimen is performed in a container, and wherein said dispensing is performed by extruding said aliquot from said container.

27. The method of claim 26 wherein said amplification regimen is performed in a container open at one or both ends.

28. The method of claim 26 wherein said container is a capillary tube.

29. A method of analyzing the expression of a plurality of RNA transcripts between first and second gene expressing entities, said method comprising

providing a first nucleic acid amplification reaction mixture, said mixture comprising a plurality of different amplification templates, wherein said amplification templates comprise reverse transcription products from a plurality of RNA transcripts from a first gene expressing entity;

providing a second nucleic acid amplification reaction mixture, said mixture comprising a plurality of different amplification templates, wherein said amplification templates comprise reverse transcription products from a plurality of RNA transcripts from a second gene expressing entity;

subjecting said reaction mixtures to an amplification regimen;

dispensing or withdrawing an aliquot from said first and said second reaction mixtures at plural stages during said amplification regimen;

separating and detecting nucleic acids in said aliquot, wherein said separating comprises capillary electrophoresis;

determining the quantity of a plurality of separated nucleic acid species in said aliquot, wherein said plurality of RNA transcripts comprises at least five different RNA transcripts

for each said separated nucleic acid species from each said stage, correlating the quantity of said species with the stage at which said aliquot comprising said species was dispensed, thereby generating a transcriptional profile of said plurality of RNA transcripts expressed by said first and said second gene expressing entities; and

comparing said transcriptional profile from said first gene expressing entity with said transcriptional profile from said second gene expressing entity, wherein said comparing provides quantitative information regarding the abundance of said plurality of different amplification templates produced by said first and second entities.

30. The method of claim 29 wherein said plurality of RNA transcripts comprises at least ten different RNA transcripts.

31. The method of claim 29 wherein said plurality of RNA transcripts comprises at least 20 different RNA transcripts.

32. The method of claim 29 wherein said plurality of RNA transcripts comprises at least 50 different RNA transcripts.

33. The method of claim 29 wherein said plurality of RNA transcripts comprises at least 100 different RNA transcripts.

34. The method of claim 29 wherein said plurality of RNA transcripts comprises at least 200 different RNA transcripts.

35. The method of claim 29 wherein said amplification regimen is cyclic.

36. The method of claim 35 wherein said nucleic acid amplification regimen comprises thermal cycling.

37. The method of claim 35 wherein said nucleic acid amplification regimen comprises isothermal cycling.

38. The method of claim 35 wherein said nucleic acid amplification regimen comprises PCR.

39. The method of claim 29 wherein said nucleic acid amplification regimen comprises ligase-mediated amplification, NASBA, and rolling circle amplification.

40. The method of claim 29 wherein said aliquot is dispensed into a receptacle having a plurality of aliquot-receiving sites.

41. The method of claim 40 wherein said receptacle is a multiwell plate.

42. The method of claim 40 wherein said receptacle comprises a plurality of CE capillaries.

43. The method of claim 35 wherein said dispensing or withdrawing is performed after a plurality of cycles.

44. The method of claim 35 wherein said dispensing or withdrawing is performed after every cycle in said regimen.

45. The method of claim 29 wherein said detecting comprises detection of one or more fluorescent labels.

46. The method of claim 29 wherein said detecting comprises mass spectrometry.

47. The method of claim 29 wherein said amplification regimen is performed in a container, and wherein said aliquot dispensing is performed by withdrawing said sample from said container.

48. The method of claim 47 wherein said container is a well or a test tube.

49. The method of claim 43 wherein said amplification regimen is performed in a container, and wherein said dispensing is performed by extruding said aliquot from said container.

50. The method of claim 49 wherein said container is a capillary tube.

51. A method of monitoring the amplification of a nucleic acid sequence, the method comprising:

providing a nucleic acid amplification reaction mixture comprising a template of said nucleic acid sequence;

performing an amplification regimen on the mixture;

automatically dispensing an aliquot of said reaction mixture at plural stage intervals throughout the amplification regimen;

separating and detecting at least five nucleic acid species in said aliquot, wherein said separating comprises capillary electrophoresis; and,

for respective ones of plural separated species, determining the quantity of separated nucleic acid in said aliquot.

52. A method of determining the transcription profile of a nucleic acid sequence, the method comprising:

providing a nucleic acid amplification reaction mixture; performing an amplification

regimen on the mixture;

dispensing an aliquot of said reaction mixture at plural stage intervals throughout the amplification regimen;

separating and detecting at least five nucleic acid species in said aliquot, wherein said separating comprises capillary electrophoresis; and,

for respective ones of plural separated species, determining the quantity of separated nucleic acid in said aliquot whereby a transcription profile is determined for said nucleic acid species, and wherein said profile provides quantitative information regarding the abundance, in said amplification reaction mixture, at the start of said amplification regimen, of said at least five nucleic acid species.

53. A method of analyzing a nucleic acid amplification comprising:

providing a nucleic acid amplification reaction mixture comprising a plurality of different amplification templates;

subjecting said reaction mixture to a PCR amplification regimen;

dispensing or withdrawing an aliquot from said reaction mixture at plural stages during said amplification regimen;

separating and detecting nucleic acids in said aliquot, wherein said separating comprises capillary electrophoresis;

determining the quantity of a plurality of separated nucleic acid species in said aliquot, and

for each said separated nucleic acid species from each said stage, correlating the quantity of said species with the stage at which said aliquot comprising said species was dispensed, wherein said correlating generates an amplification profile of said nucleic acid amplification, and wherein said amplification profile provides quantitative information regarding the abundance of said plurality of different amplification templates in said amplification reaction mixture at the start of said amplification regimen.

54. A method of analyzing the expression of a plurality of RNA transcripts between first and second gene expressing entities, said method comprising

providing a first nucleic acid amplification reaction mixture, said mixture comprising a plurality of different amplification templates, wherein said amplification templates comprise reverse transcription products from a plurality of RNA transcripts from a first gene expressing entity;

providing a second nucleic acid amplification reaction mixture, said mixture comprising a plurality of different amplification templates, wherein said amplification templates comprise reverse transcription products from a plurality of RNA transcripts from a second gene expressing entity;

subjecting said reaction mixtures to a PCR amplification regimen;

dispensing or withdrawing an aliquot from said first and said second reaction mixtures at plural stages during said amplification regimen;

separating and detecting nucleic acids in said aliquot, wherein said separating comprises capillary electrophoresis;

determining the quantity of a plurality of separated nucleic acid species in said aliquot,

for each said separated nucleic acid species from each said stage, correlating the quantity of said species with the stage at which said aliquot comprising said species was dispensed, thereby generating a transcriptional profile of said plurality of RNA transcripts expressed by said first and said second gene expressing entities; and

comparing said transcriptional profile from said first gene expressing entity with said transcriptional profile from said second gene expressing entity, wherein said comparing provides quantitative information regarding the abundance of said plurality of different amplification templates produced by said first and second entities.

55. A method of monitoring the amplification of a nucleic acid sequence, the method comprising:

providing a nucleic acid amplification reaction mixture comprising a template of said nucleic acid sequence;

performing a PCR amplification regimen on the mixture;

automatically dispensing an aliquot of said reaction mixture at plural stage intervals throughout the amplification regimen;

separating and detecting the nucleic acid species in said aliquot, wherein said separating comprises capillary electrophoresis; and,

for respective ones of plural separated species, determining the quantity of separated nucleic acid in said aliquot.

56. A method of determining the transcription profile of a nucleic acid sequence, the method comprising:

providing a nucleic acid amplification reaction mixture;

performing a PCR amplification regimen on the mixture;

dispensing an aliquot of said reaction mixture at plural stage intervals throughout the amplification regimen;

separating and detecting the nucleic acid species in said aliquot, wherein said separating comprises capillary electrophoresis; and,

for respective ones of plural separated species, determining the quantity of separated nucleic acid in said aliquot;

whereby a transcription profile is determined for said nucleic acid species, and wherein said profile provides quantitative information regarding the abundance, in said amplification reaction mixture, at the start of said amplification regimen, of said nucleic acid species.

57. A method of analyzing a nucleic acid amplification comprising:

providing a nucleic acid amplification reaction mixture comprising a plurality of different amplification templates;

subjecting said reaction mixture to a PCR amplification regimen;

dispensing or withdrawing an aliquot from said reaction mixture at plural stages during said amplification regimen;

separating and detecting nucleic acids in said aliquot, wherein said separating comprises capillary electrophoresis;

determining the quantity of a plurality of separated nucleic acid species in said aliquot,

for each said separated nucleic acid species from each said stage, correlating the quantity of said species with the stage at which said aliquot comprising said species was dispensed, and

calculating a threshold cycle for the amplification product of each of said plurality of different amplification templates, wherein said threshold cycle permits calculation of the abundance, at the start of said amplification regimen, of said plurality of different amplification templates in said amplification reaction mixture.

58. A method of analyzing the expression of a plurality of RNA transcripts between first and second gene expressing entities, said method comprising

providing a first nucleic acid amplification reaction mixture, said mixture comprising a plurality of different amplification templates, wherein said amplification templates comprise reverse transcription products from a plurality of RNA transcripts from a first gene expressing entity;

providing a second nucleic acid amplification reaction mixture, said mixture comprising a plurality of different amplification templates, wherein said amplification templates comprise reverse transcription products from a plurality of RNA transcripts from a second gene expressing entity;

subjecting said reaction mixtures to a PCR amplification regimen;

dispensing or withdrawing an aliquot from said first and said second reaction mixtures at plural stages during said amplification regimen;

separating and detecting nucleic acids in said aliquot, wherein said separating comprises capillary electrophoresis;

determining the quantity of a plurality of separated nucleic acid species in said aliquot,

for each said separated nucleic acid species from each said stage, correlating the quantity of said species with the stage at which said aliquot comprising said species was dispensed,

calculating a threshold cycle for the amplification product of each of said plurality of different amplification templates, wherein said threshold cycle permits calculation of the abundance, at the start of said amplification regimen, of said pluralities of different amplification templates in said first and second amplification reaction mixtures.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2021
From: MDG MOLECULAR DIAGNOSTICS GROUP GMBH
To: BIOTYPE DIAGNOSTIC GMBH
Reel/Frame 056808/0683 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME PREVIOUSLY RECORDED AT REEL: 053819 FRAME: 0539. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Jul 9, 2021
From: QIAGEN MANSFIELD, INC.
To: MDG MOLECULAR DIAGNOSTICS GROUP GMBH
Reel/Frame 057667/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2020
From: BIOTYPE DIAGNOSTIC GMBH
To: BIOTYPE INNOVATION GMBH
Reel/Frame 053815/0099 →
CHANGE OF NAME Recorded Sep 18, 2020
From: BIOTYPE INNOVATION GMBH
To: BIOTYPE GMBH
Reel/Frame 053815/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2020
From: QIAGEN MANSFIELD, INC.
To: MOLECULAR DIAGNOSTICS GROUP GMBH
Reel/Frame 053819/0539 →
CHANGE OF NAME Recorded Nov 5, 2014
From: PRIMERADX, INC.
To: QIAGEN MANSFIELD, INC.
Reel/Frame 034176/0198 →
CHANGE OF NAME Recorded Nov 10, 2009
From: PRIMERA BIOSYSTEMS, INC.
To: PRIMERADX, INC.
Reel/Frame 023493/0464 →
CHANGE OF NAME Recorded Feb 13, 2006
From: PRIMERA DIAGNOSTICS, INC.
To: PRIMERA BIOSYSTEMS, INC.
Reel/Frame 017196/0284 →
INVALID RECORDING, PLEASE SEE RECORDING AT 017309/0447 Recorded Aug 22, 2005
From: SENTION, INC.
To: PRIMERA BIOSYSTEMS, INC.
Reel/Frame 017287/0965 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2005
From: SENTION, INC.
To: PRIMERA DIAGNOSTICS, INC.
Reel/Frame 017309/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2004
From: SLEPNEV, VLADIMIR I.
To: SENTION INC.
Reel/Frame 014495/0772 →